A New RNA Catalyst From the Lab

The schematically shown ribozyme (green) binds to the target RNA (blue) by base pairing and installs the methyl group (red flag) at a defined site of a selected adenine. The reaction product m1A is shown in the red circle.
Claudia Höbartner / University of Würzburg

On the track of evolution: a catalytically active RNA molecule that specifically attaches methyl groups to other RNAs – a research group from the University of Würzburg reports on this new discovery in “Nature”.

Enzymes enable biochemical reactions that would otherwise not take place on their own. In nature, it is mostly proteins that function as enzymes. However, other molecules can also perform enzymatic reactions – for example ribonucleic acids, RNAs. These are then called ribozymes.

In this field, the research group of chemistry professor Claudia Höbartner is now reporting a scientific breakthrough: Her team at Julius-Maximilians-Universität Würzburg (JMU) in Bavaria, Germany, has developed a ribozyme that can attach a very specific small chemical change at a very specific location in a target RNA.

More precisely: the ribozyme transfers a single methyl group to an exactly defined nitrogen atom of the target RNA. This makes it the first known methyl transferase ribozyme in the world. Accordingly, Höbartner’s group has given it the short name MTR1.

In the journal Nature the group presents details about the new ribozyme. In the target RNA, it produces the methylated nucleoside 1-methyladenosine (m1A). The methyl group is transferred from a free methylated guanine nucleobase (O6-methylguanine, m6G) in a binding pocket of the ribozyme.

Ribozymes in evolution

The ribozyme discovered at the JMU Institute of Organic Chemistry sheds light on an interesting aspect of evolution. According to the “RNA world hypothesis”, RNA was one of the first information-storing and enzymatically active molecules. Ribozymes similar to those developed by Claudia Höbartner and her team may have produced methylated RNAs in the course of evolution. This in turn may have led to a greater structural and thus functional diversity of RNA molecules.

In nature, methyl groups are installed on RNAs by specialised protein enzymes. These proteins use cofactors that contain RNA-like components. “It is reasonable to assume that these cofactors could be evolutionary ‘leftovers’ of earlier enzymatically active RNAs. Our discovery may therefore mimic a ribozyme that has possibly been lost in nature a long time ago,” says Claudia Höbartner.

In the laboratory, new or naturally extinct ribozymes can be found by a method called in vitro evolution. “It starts from many different sequences of synthetic RNA, and is analogous to finding a needle in the haystack”, says co-author Mohammad Ghaem Maghami, a postdoctoral researcher in the Höbartner group.

New ribozyme also acts on natural RNA

The authors have also been able to show that MTR1 can install a single methyl group not only on synthetic RNA structures but also on natural RNA strands found in cells.

This news is likely to attract great attention from cell biologists, among others. The reason for this is that the methylation of RNA can be considered as a biochemical on or off switch. It has a key role in the functioning of RNA structures and can control many life processes in the cell.

The newly developed ribozyme MTR1 is expected to be a useful tool for a wide range of research areas in the future. “For example, it could help to better understand the interaction of methylation, structure, and function of RNA,” explains JMU PhD student Carolin Scheitl, the first author of the publication in Nature.

The next steps of the researchers

Many new projects will build on these results. Höbartner’s group intends to solve the structure of their new ribozyme and reveal the detailed chemical mechanism of the RNA-catalyzed methylation. With the methods now established, her team will also be able to develop ribozymes for a variety of other reactions.

According to the JMU professor, these ribozymes also offer an excellent possibility to control Watson-Crick base pairing and to install fluorescent labels for RNA imaging.


This work was financially supported by the European Research Council (ERC Consolidator Grant “Illumizymes”, Grant Number 682586 to Prof. Dr. Claudia Höbartner) and the Priority Programme “Chemical Biology of Natural Nucleic Acid Modifications” (SPP 1784) of the German Research Foundation (DFG).

Wissenschaftliche Ansprechpartner:

Prof. Dr. Claudia Höbartner, Chair of Organic Chemistry I, University of Würzburg, T +49 931 31-89693, claudia.hoebartner@uni-wuerzburg.de


Site-specific RNA methylation by a methyltransferase ribozyme, Carolin Scheitl, Mohammad Ghaem Maghami, Ann-Kathrin Lenz and Claudia Höbartner, Nature, 28 October 2020, DOI: 10.1038/s41586-020-2854-z


Media Contact

Robert Emmerich Presse- und Öffentlichkeitsarbeit
Julius-Maximilians-Universität Würzburg

Alle Nachrichten aus der Kategorie: Life Sciences

Articles and reports from the Life Sciences area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

How Stable is the Antarctic Ice Sheet?

Scientists from Heidelberg University investigate which factors determine the stability of ice masses in East Antarctica. As temperatures rise due to climate change, the melting of polar ice sheets is…

Smart sensors for future fast charging batteries

European project “Spartacus” launched Faster charging, longer stability of performance not only for electric vehicles but also for smartphones and other battery powered products. What still sounds like science fiction…

Small molecules control bacterial resistance to antibiotics

Antibiotics have revolutionized medicine by providing effective treatments for infectious diseases such as cholera. But the pathogens that cause disease are increasingly developing resistance to the antibiotics that are most…


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.